Market Price

26.60 

-0.64 -2.4%

as of Apr 12 '21

52 Week Range:

10.60 41.99


Stock Analyzer Tutorials

S2O Stock Analyzer - General Info

General Info


type: video (mp4); length: 3:30

Demonstrates how to use Stock Analyzer, shows how to analyze a stock and explains in detail "General Info" section of the Stock Analyzer result page.

S2O Stock Analyzer - Financial Statements

Financial Statements


type: video (mp4); length: 5:10

Explains information presented in the Financial Statements section of the S2O Stock Analyzer: financial statements charts, absolute values and growth rates.

S2O Stock Analyzer - Growth Grade and Financial Ratios

Growth Grade and Financial Ratios


type: video (mp4); length: 5:09

Demonstrates how to use Growth Grade & Financial Ratios section; shows the difference between historical and year-over-year Growth Grade on the real life example.

S2O Stock Analyzer - Value Price

Value Price


type: video (mp4); length: 6:03

Demonstrates how to use Value Price (intrinsic value) and the Graham Number, MOS (margin of safety) and IRT - Investment Recovery Time; explains 3 different projection models used to compute value price - pessimistic, moderate and optimistic.

S2O Stock Analyzer - Price Charts

Price Charts


type: video (mp4); length: 8:34

Demonstrates basic rules of how to read a candlestick chart, long and short term moving averages, stochastic, MACD and relative strength (RS) charts. Explains how bull or bear market condition is computed.

General Info

Core Laboratories N.V. provides reservoir description, and production enhancement services and products to the oil and gas industry in the United States, Canada, and internationally. It operates in two segments, Reservoir Description and Production Enhancement segments. The Reservoir Description segment comprises the characterization of petroleum reservoir rock, fluid, and gas samples to enhance production and improve recovery of oil and gas from its clients' reservoirs. This segment offers laboratory-based analytical and field services to characterize properties of crude oil and petroleum products to the oil and gas industry. It also provides proprietary and joint industry studies. The Production Enhancement segment includes services and products relating to reservoir well completions, perforations, stimulations, and production. This segment offers integrated diagnostic services to evaluate and monitor the effectiveness of well completions and to develop solutions to improve the effectiveness of enhanced oil recovery projects. The company markets and sells its products through a combination of sales representatives, technical seminars, trade shows, and print advertising, as well as through distributors. Core Laboratories N.V. was founded in 1936 and is based in Amsterdam, the Netherlands.

Financial Statements

The charts below show selected Annual and Quarterly Financial Data.

The purpose of these charts is to discover long and short term change dynamics. When numbers are growing year after year in the annual statements chart, the business become stronger and stronger and this is a good sign.

Quarterly Data Chart can be used to do a short term analysis. It makes sense to pay attention to the quarterly dynamics and do not wait for the next yearly statement. We should be alerted if we see that quarterly numbers are going down.

You can check "Annual Financial Statements" and "Quarterly Financial Statements" sections for exact numbers and growth rates.

Annual Statements

On a charts below the Line shows absolute values and the Bar chart shows Year-Over-Year Growth Rate for selected financial statement item. A consistent GROWTH is generally considered necessary to fund future growth from within a business.
NOTE: Growth Rate is not provided if either the latest period or the year-ago period contains a net loss. (source: WSJ Digest of Earnings)
TIP! move your mouse pointer over bar or a circle on any chart below to see details.

Financial Statements

Income Statement



 

Cash Flow Statement



 

Balance Sheet



 

Liquidity Ratios

Current Ratio


 

Current Ratio measures the ability to meet short term obligations. Generally accepted standard is 2 (current assets should be 2 times or 200% of current liabilities).

Quick Ratio


 

Measures immediate liquidity or the cash available to cover immediate liabilities. A safe margin would be at least 1 (100%).

Financial Leverage


 

Defined as total assets divided by total shareholders' equity. The higher the ratio, the more debt a company uses in its capital structure.

Profitability Ratios

ROA


 

Return on Assets (ROA) measures the income (profit) that is generated by the use of the assets of the business.

ROE


 

Return on Equity (ROE) is a measure of profitability that calculates how many dollars of profit a company generates with each dollar of shareholders equity. ROE is sometimes called "return on net worth."

ROIC


 

The Return on Invested Capital (ROIC) measure gives a sense of how well a company is using its money to generate returns. Some investors use this figure as a final evaluation to determine whether or not to invest in a company.

Annual Statements

Item Name Dec '10 Dec '11 Dec '12 Dec '13 Dec '14 Dec '15 Dec '16 Dec '17 Dec '18 Dec '19 Dec '20
Equity (BVPS) 6.36
2.82
3.93
3.95
2.19
-0.29
3.57
3.38
3.55
4.28
1.52
growth rate -55.7% 39.4% 0.5% -44.6% -100.0% 100.0% -5.3% 5.0% 20.6% -64.5%
Earnings BIT 209.15
238.84
288.46
324.10
348.94
187.63
88.10
111.39
119.86
102.02
49.63
growth rate 14.2% 20.8% 12.4% 7.7% -46.2% -53.0% 26.4% 7.6% -14.9% -51.4%
Avg.PE 29.67
29.85
24.04
36.23
19.92
40.03
78.16
55.80
52.24
52.24
52.24
growth rate 0.6% -19.5% 50.7% -45.0% 101.0% 95.3% -28.6% -6.4% 0.0% 0.0%
ROA 22.39
29.76
34.80
37.43
38.53
17.66
10.66
14.36
12.89
14.33
-14.54
growth rate 32.9% 16.9% 7.6% 2.9% -54.2% -39.6% 34.7% -10.2% 11.2% -100.0%
ROE 50.95
79.03
120.00
140.53
205.25
392.58
104.50
56.13
52.74
60.95
-78.30
growth rate 55.1% 51.8% 17.1% 46.1% 91.3% -73.4% -46.3% -6.0% 15.6% -100.0%
ROIC 28.82
45.48
54.44
58.88
60.72
29.42
19.17
24.85
21.90
22.20
-18.13
growth rate 57.8% 19.7% 8.2% 3.1% -51.6% -34.8% 29.6% -11.9% 1.4% -100.0%
Cur. Ratio 1.25
2.04
2.11
2.23
2.29
1.98
1.79
1.98
2.25
1.98
1.85
growth rate 63.2% 3.4% 5.7% 2.7% -13.5% -9.6% 10.6% 13.6% -12.0% -6.6%
Quick Ratio 1.03
1.45
1.58
1.71
1.76
1.45
1.30
1.47
1.52
1.33
1.19
growth rate 40.8% 9.0% 8.2% 2.9% -17.6% -10.3% 13.1% 3.4% -12.5% -10.5%
Leverage 2.20
3.40
3.49
4.05
7.72
3.79
4.04
4.14
4.36
7.95
growth rate 54.6% 2.7% 16.1% 90.6% -29.9% 6.6% 2.5% 5.3% 82.3%
Balance Sheet Dec '10 Dec '11 Dec '12 Dec '13 Dec '14 Dec '15 Dec '16 Dec '17 Dec '18 Dec '19 Dec '20
Acct.Receivable 154.70
177.95
203.00
206.62
208.14
152.90
120.76
140.61
143.15
138.11
92.87
growth rate 15.0% 14.1% 1.8% 0.7% -26.5% -21.0% 16.4% 1.8% -3.5% -32.8%
Acct.Payable 124.04
55.00
124.89
47.08
33.47
33.72
41.70
41.16
35.61
23.03
growth rate -55.7% 127.1% -62.3% -28.9% 0.7% 23.7% -1.3% -13.5% -35.3%
Cur.Assets 349.30
286.55
297.00
303.87
301.82
238.55
186.46
207.43
230.98
221.24
165.85
growth rate -18.0% 3.7% 2.3% -0.7% -21.0% -21.8% 11.2% 11.4% -4.2% -25.0%
Total Assets 636.00
610.87
637.00
661.01
673.33
625.26
573.05
584.81
648.83
774.67
568.58
growth rate -4.0% 4.3% 3.8% 1.9% -7.1% -8.4% 2.1% 11.0% 19.4% -26.6%
Cash 133.90
29.33
19.00
25.09
23.35
22.49
14.76
14.40
13.12
11.09
13.81
growth rate -78.1% -35.2% 32.0% -6.9% -3.7% -34.4% -2.5% -8.9% -15.4% 24.5%
Inventory 34.00
53.21
49.00
46.82
43.37
40.91
33.72
33.32
45.66
50.16
38.15
growth rate 56.5% -7.9% -4.5% -7.4% -5.7% -17.6% -1.2% 37.1% 9.9% -24.0%
Cur.Liabilities 279.40
143.20
141.00
135.78
131.87
120.76
104.02
100.58
102.55
111.59
89.75
growth rate -48.8% -1.5% -3.7% -2.9% -8.4% -13.9% -3.3% 2.0% 8.8% -19.6%
Liabilities 346.60
432.97
449.00
497.69
579.33
648.96
417.76
436.08
487.93
592.53
493.01
growth rate 24.9% 3.7% 10.8% 16.4% 12.0% -35.6% 4.4% 11.9% 21.4% -16.8%
LT Debt 8.90
223.08
234.00
267.00
354.75
432.57
217.53
227.48
289.84
306.34
261.92
growth rate 2,406.5% 4.9% 14.1% 32.9% 21.9% -49.7% 4.6% 27.4% 5.7% -14.5%
Equity 289.50
177.90
182.23
163.32
87.57
-29.06
151.35
144.84
156.76
177.87
71.51
growth rate -38.6% 2.4% -10.4% -46.4% -100.0% 100.0% -4.3% 8.2% 13.5% -59.8%
Common Shares 48.00
48.00
48.00
46.00
45.00
43.00
44.00
44.00
44.00
45.00
44.00
growth rate 0.0% 0.0% -4.2% -2.2% -4.4% 2.3% 0.0% 0.0% 2.3% -2.2%
Cash Flow Statement Dec '10 Dec '11 Dec '12 Dec '13 Dec '14 Dec '15 Dec '16 Dec '17 Dec '18 Dec '19 Dec '20
Capital Expenditures -0.70
29.93
31.00
35.42
36.59
22.80
11.36
18.78
21.74
22.27
11.88
growth rate 100.0% 3.6% 14.3% 3.3% -37.7% -50.2% 65.3% 15.8% 2.4% -46.7%
Cash Dividends 40.00
46.28
53.25
58.64
89.09
94.24
95.15
97.14
97.25
97.57
12.45
growth rate 15.7% 15.1% 10.1% 51.9% 5.8% 1.0% 2.1% 0.1% 0.3% -87.2%
Cash From OA 205.80
204.13
237.00
298.14
303.45
219.10
131.89
124.27
111.83
89.53
57.87
growth rate -0.8% 16.1% 25.8% 1.8% -27.8% -39.8% -5.8% -10.0% -19.9% -35.4%
FCF per Share 3.69
3.22
4.30
5.57
5.69
5.52
3.37
1.88
2.21
1.85
1.74
growth rate -12.7% 33.5% 29.5% 2.2% -3.0% -39.0% -44.2% 17.6% -16.3% -6.0%
Sale Purchase of Stock -279.79
-173.93
-227.13
197.20
197.20
197.20
-16.91
growth rate 0.0% 0.0% 100.0% 0.0% 0.0% -100.0%
FCF 178.00
174.00
204.00
259.00
266.00
195.00
120.00
105.00
89.00
67.00
45.00
growth rate -2.3% 17.2% 27.0% 2.7% -26.7% -38.5% -12.5% -15.2% -24.7% -32.8%
Income Statement Dec '10 Dec '11 Dec '12 Dec '13 Dec '14 Dec '15 Dec '16 Dec '17 Dec '18 Dec '19 Dec '20
Sales 794.70
907.65
981.00
1,073.51
1,085.22
797.52
590.23
647.82
700.85
668.21
487.27
growth rate 14.2% 8.1% 9.4% 1.1% -26.5% -26.0% 9.8% 8.2% -4.7% -27.1%
Op.Income 226.90
184.68
217.00
242.81
348.94
187.63
88.10
111.39
119.86
102.02
49.63
growth rate -18.6% 17.5% 11.9% 43.7% -46.2% -53.0% 26.4% 7.6% -14.9% -51.4%
IBT 209.10
238.84
288.46
324.10
335.93
148.69
75.88
99.23
105.29
81.99
-91.18
growth rate 14.2% 20.8% 12.4% 3.7% -55.7% -49.0% 30.8% 6.1% -22.1% -100.0%
Net Income 144.90
184.68
217.00
242.81
257.49
114.85
63.90
83.13
79.53
101.98
-97.64
growth rate 27.5% 17.5% 11.9% 6.0% -55.4% -44.4% 30.1% -4.3% 28.2% -100.0%
EPS 3.00
3.82
4.54
5.28
5.77
2.68
1.46
1.88
1.79
2.28
-2.20
growth rate 27.3% 18.9% 16.3% 9.3% -53.6% -45.5% 28.8% -4.8% 27.4% -100.0%
Gross Profit 280.90
314.28
359.00
410.54
419.95
264.87
152.73
182.86
203.88
172.63
102.13
growth rate 11.9% 14.2% 14.4% 2.3% -36.9% -42.3% 19.7% 11.5% -15.3% -40.8%
R&D 0.00
growth rate

Quarterly Statements

Item Name Dec '19 Mar '20 Jun '20 Sep '20 Dec '20
Earnings BIT 21.06
13.79
10.15
12.02
23.85
growth rate -34.5% -26.4% 18.5% 98.4%
Balance Sheet Dec '19 Mar '20 Jun '20 Sep '20 Dec '20
Acct.Receivable 138.11
132.77
110.00
93.46
92.87
growth rate -3.9% -17.2% -15.0% -0.6%
Acct.Payable 35.61
37.05
23.69
22.81
23.03
growth rate 4.1% -36.1% -3.7% 1.0%
Cur.Assets 221.24
219.71
191.39
169.89
165.85
growth rate -0.7% -12.9% -11.2% -2.4%
Total Assets 774.67
646.61
614.44
590.81
568.58
growth rate -16.5% -5.0% -3.9% -3.8%
Cash 11.09
13.89
20.96
15.15
13.81
growth rate 25.2% 50.9% -27.7% -8.9%
Inventory 50.16
52.26
41.53
42.91
38.15
growth rate 4.2% -20.5% 3.3% -11.1%
Cur.Liabilities 111.59
108.45
99.28
172.14
89.75
growth rate -2.8% -8.5% 73.4% -47.9%
Liabilities 651.24
576.54
548.29
519.11
493.01
growth rate -11.5% -4.9% -5.3% -5.0%
LT Debt 306.34
304.77
289.06
191.88
261.92
growth rate -0.5% -5.2% -33.6% 36.5%
Equity 177.87
65.72
62.10
67.63
71.51
growth rate -63.1% -5.5% 8.9% 5.7%
Common Shares 44.47
1.15
1.15
1.15
1.15
growth rate -97.4% 0.0% 0.0% 0.0%
Cash Flow Statement Dec '19 Mar '20 Jun '20 Sep '20 Dec '20
Capital Expenditures 4.73
3.34
3.07
2.17
3.30
growth rate -29.4% -8.2% -29.2% 52.0%
Cash Dividends -24.41
11.11
0.45
0.45
0.45
growth rate 100.0% -96.0% 0.0% 0.0%
Cash From OA 21.30
22.03
27.00
20.69
-2.91
growth rate 3.4% 22.6% -23.4% -100.0%
Sale Purchase of Stock
growth rate
FCF 16.57
18.69
23.93
18.52
-6.21
growth rate 12.8% 28.1% -22.6% -100.0%
Income Statement Dec '19 Mar '20 Jun '20 Sep '20 Dec '20
Sales 154.53
152.40
115.74
105.38
113.75
growth rate -1.4% -24.1% -9.0% 7.9%
Op.Income 21.06
13.79
10.15
12.02
23.85
growth rate -34.5% -26.4% 18.5% 98.4%
IBT 17.51
-112.38
-5.94
6.66
20.48
growth rate -100.0% 0.0% 100.0% 207.6%
Net Income 10.33
-108.42
-5.72
2.96
13.54
growth rate -100.0% 0.0% 100.0% 356.9%
EPS
growth rate
Gross Profit -2.25
37.27
25.06
24.34
25.83
growth rate 100.0% -32.8% -2.8% 6.1%
R&D
growth rate

Growth Grade & Financial Ratios

All financial ratios below are calculated based on latest annual statements available and present the most up to date snapshot of a company finances.

Growth Grade

Historical Growth Grade:

F (0.00)

YOY Growth Grade:

F (3.68)

Click on buttons above for detailed yearly growth rates.

Market Ratios

Profitability Ratios

Liquidity Ratios

Efficiency Ratios

Value Price

PE and EPS

Historical Current Forward
PE 52.24 12.96 35.87
EPS / Growth -25.5% 2.05 31.3%

Value Price & Investment Recovery Time

Read more about Stock2Own value price in Stock Market: Fundamental Analysis.

Equity Growth Rate: 1.0%

Estimates Pessimistic Moderate Optimistic My Numbers
Rate of Return 15.0%
MOS Price % 50 %
Future EPS Growth 1.0% 1.0% 1.0%
Future PE 2.00 30.04 30.04
Future EPS 2.27 2.27 2.27
Value Price
MOS %
1.12
-95.8%
16.84
-36.7%
16.84
-36.7%
MOS Price 0.56 8.42 8.42
IRT 12.13 12.13 12.13

Graham Number:

NOTE: The Graham Number applies only to certain types of stocks in combination with a number of other criteria.

Read more about Graham Number in Stock Market: Fundamental Analysis.

Price Chart

The functionality you are trying to reach is available to registered users only.

Login to your account or Register Now if you are not registered yet. Registration is FREE and will take only a minute.

Risk / Reward Ratios

The functionality you are trying to reach is available to registered users only.

Login to your account or Register Now if you are not registered yet. Registration is FREE and will take only a minute.